• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

Recent Advances in the Study of 4(3H)-Pyrimidinone (CAS: 542-27-8) in Chemical Biology and Pharmaceutical Research

4(3H)-Pyrimidinone (CAS: 542-27-8) is a heterocyclic compound that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile pharmacological properties and its role as a key scaffold in drug discovery. Recent studies have explored its potential as a building block for novel therapeutic agents, particularly in the areas of antiviral, anticancer, and antimicrobial drug development. This research brief synthesizes the latest findings on the synthesis, biological activity, and applications of 4(3H)-pyrimidinone derivatives.

One of the most notable advancements in this field is the development of novel synthetic routes for 4(3H)-pyrimidinone derivatives. A 2023 study published in the Journal of Medicinal Chemistry demonstrated an efficient one-pot synthesis method using microwave-assisted reactions, which significantly improved yield and reduced reaction time compared to traditional methods. The study also highlighted the importance of structural modifications at the N-1 and C-6 positions of the pyrimidinone ring for enhancing biological activity. These modifications have led to the discovery of compounds with potent inhibitory effects against viral polymerases, suggesting potential applications in antiviral therapy.

In the realm of anticancer research, 4(3H)-pyrimidinone derivatives have shown promise as kinase inhibitors. A recent preclinical study (Nature Communications, 2024) identified a series of 4(3H)-pyrimidinone-based compounds that selectively target cyclin-dependent kinases (CDKs), particularly CDK4/6, which are crucial regulators of the cell cycle. These compounds exhibited nanomolar potency in vitro and demonstrated significant tumor growth inhibition in xenograft models of breast cancer. The researchers emphasized the favorable pharmacokinetic properties of these derivatives, including good oral bioavailability and blood-brain barrier penetration, which make them attractive candidates for further development.

The antimicrobial potential of 4(3H)-pyrimidinone derivatives has also been extensively investigated. A 2023 study in the European Journal of Medicinal Chemistry reported the design and synthesis of novel 4(3H)-pyrimidinone hybrids with fluoroquinolone moieties. These hybrids displayed broad-spectrum activity against multidrug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Molecular docking studies revealed that these compounds interact with both DNA gyrase and topoisomerase IV, providing a dual mechanism of action that may delay the development of bacterial resistance.

Beyond its direct therapeutic applications, 4(3H)-pyrimidinone has emerged as a valuable tool in chemical biology. Researchers have developed fluorescent derivatives of 4(3H)-pyrimidinone that serve as sensitive probes for monitoring enzymatic activity in real-time. A recent publication in Chemical Science (2024) described the use of these probes to study the dynamics of nucleotide metabolism in live cells, providing new insights into cellular energy regulation and nucleotide salvage pathways. This application highlights the compound's versatility beyond traditional drug discovery.

In conclusion, recent research on 4(3H)-pyrimidinone (CAS: 542-27-8) demonstrates its continued importance in pharmaceutical development and chemical biology. The compound's structural flexibility allows for diverse modifications that can yield molecules with specific biological activities. While significant progress has been made in understanding its pharmacological potential, challenges remain in optimizing the drug-like properties of these derivatives and translating preclinical findings into clinical applications. Future research directions may include the exploration of 4(3H)-pyrimidinone derivatives in combination therapies and the development of more efficient synthetic methodologies to facilitate large-scale production.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)